Skip to main content
Clinical Trials/PACTR202006539654415
PACTR202006539654415
Completed
未知

Evaluation of the safety and efficacy of platelet rich plasma in treatment of patients with chronic telogen effluvium: a randomized controlled, patient blind, evaluator blind, clinical trial.

Faculty of Medicine Sohag University0 sites30 target enrollmentApril 20, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Skin and Connective Tissue Diseases
Sponsor
Faculty of Medicine Sohag University
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 20, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Faculty of Medicine Sohag University

Eligibility Criteria

Inclusion Criteria

  • female patients
  • chronic telogen effluvium patients (diffuse hair falling more than 6 months)
  • aged between 18 and 55 years

Exclusion Criteria

  • ?Pregnant and lactating women.
  • ?Patients having any dermatological diseases affecting the scalp.
  • ?Thyroid dysfunction.
  • ?Chronic medical diseases.
  • ?Patients with anemia (hemoglobin level \<10mg/dl), thrombocytopenia (platelet count \< 100,000 /µL), coagulopathies or patients on anticoagulant therapy as aspirin and patients with iron deficiency.
  • ?Patients received topical or systemic treatment for hair loss in the last three months before the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials